Prenuvo, headquartered in Canada, remains privately held in the healthcare/diagnostics space. Its shares do not trade on a public exchange.
Prenuvo has no published valuation.
Khosla Ventures
Insight PartnersPrenuvo is a medical imaging company offering preventive whole-body MRI screening designed to identify potential health conditions earlier. Its scans are radiation-free and non-invasive, read by a dedicated medical group of board-certified radiologists, MRI technologists and preventative health physicians.
The company has been trusted by more than 200,000 patients and works with an affiliated network of more than 200 healthcare professionals. Prenuvo counts investors such as 23andMe's Anne Wojcicki, Nest founder Tony Fadell and Google's Eric Schmidt among its individual backers, alongside institutional venture firms.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Prenuvo.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Prenuvo availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Prenuvo included.
The closest healthcare/diagnostics peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Prenuvo is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
